Report on the Sixth International Meeting of the European Laboratory Working Group on Diphtheria, Brussels, Belgium.
In addition to the Eastern European resurgence of diphtheria during the last decade, there has also been an emergence of infections caused by non-toxigenic Corynebacterium diphtheriae and non-toxigenic, toxin gene bearing C. diphtheriae. Given that these strains may manifest as symptomatic infections of differing degrees of severity, their clinical and epidemiological significance need to be assessed. The persistence of toxigenic and non-toxigenic C. diphtheriae in circulation, together with genotypic and biotype variability means that innovative measures to vaccinate populations are pertinent. The most effective method of protecting the currently most vulnerable population group (adults) is to implement a booster dose of vaccine amongst the adult populations. Furthermore, in combination with an efficient surveillance system, effective antibiotic prophylaxis and an up-to-date vaccination programme, serological studies needs to be maintained to monitor the immunity status of the population.
Lai
S
S
WHO Collaborating Centre for Diphtheria and Streptococcal Infections, Respiratory and Systemic Infection Laboratory, PHLS Central Public Health Laboratory, London, England.
Efstratiou
A
A
D000328:Adult; D002648:Child; D003352:Corynebacterium / Q000472:pathogenicity; D003353:Corynebacterium diphtheriae / Q000472:pathogenicity; D004165:Diphtheria / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology; D004167:Diphtheria Toxin / Q000302:isolation & purification; D004168:Diphtheria Toxoid; D005060:Europe / Q000453:epidemiology; D006801:Humans
D004167:Diphtheria Toxin; D004168:Diphtheria Toxoid